Selected cytokine pathways in rheumatoid arthritis
The DOI matches its Crossref record; 234 of the 234 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528 · cited 1×
“macrophages into M1 pro-inflammatory phenotype [80, 160, 79, 212].”
Smolen, J. S., Aletaha, D., & McInnes, I. B. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30173-8 · Cited by 4,870
The TNF and TNF Receptor Superfamilies
Locksley, R. M., Killeen, N., & Lenardo, M. J. (2001) · Cell · doi:10.1016/s0092-8674(01)00237-9 · Cited by 3,650
Signalling pathways of the TNF superfamily: a double-edged sword
Aggarwal, B. B. (2003) · Nature Reviews Immunology · doi:10.1038/nri1184 · Cited by 2,793 · cited 9×
“TNFR2 recruits TNFR-associated factor 2 (TRAF2) to form TNFR2- complex I.”
BackgroundInfluentialCytokines in the pathogenesis of rheumatoid arthritis
McInnes, I. B., & Schett, G. (2007) · Nature Reviews Immunology · doi:10.1038/nri2094 · Cited by 2,529
ROLE OF CYTOKINES IN RHEUMATOID ARTHRITIS
Feldmann, M., Brennan, F. M., & Maini, R. N. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.397 · Cited by 2,514
IL-6 as a keystone cytokine in health and disease
Hunter, C. A., & Jones, S. A. (2015) · Nature Immunology · doi:10.1038/ni.3153 · Cited by 2,511 · cited 6×
“IL-6 is a pleiotropic cytokine displaying very diverse activities and produced by almost all stromal and immune cells [120].”
BackgroundInfluentialInterleukin-17 Family Members and Inflammation
Kolls, J. K., & Lindén, A. (2004) · Immunity · doi:10.1016/j.immuni.2004.08.018 · Cited by 2,372
Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
Dinarello, C. A. (2011) · Blood · doi:10.1182/blood-2010-07-273417 · Cited by 2,248
Inflammation-induced cancer: Crosstalk between tumours, immune cells and microorganisms
Elinav, E., Nowarski, R., Thaiss, C. A., Hu, B., Jin, C., & Flavell, R. A. (2013) · Nature reviews. Cancer · doi:10.1038/nrc3611 · Cited by 2,000
The interleukin-1 family: back to the future
Garlanda, C., Dinarello, C. A., & Mantovani, A. (2013) · Immunity · doi:10.1016/j.immuni.2013.11.010 · Cited by 1,945 · cited 3×
“IL-1, secreted mainly by macrophages, monocytes, and dendritic cells, was the first interleukin to be identified; it was described as a protein-inducing fever with two major proteins, IL-1α and IL-1β encoded by two distinct genes [64, 85, 90].”
BackgroundFibroblast‐like synoviocytes: key effector cells in rheumatoid arthritis
Bartok, B., & Firestein, G. S. (2010) · Immunological Reviews · doi:10.1111/j.0105-2896.2009.00859.x · Cited by 1,906
Acosta-Rodriguez, E. V., Napolitani, G., Lanzavecchia, A., & Sallusto, F. (2007) · Nature Immunology · doi:10.1038/ni1496 · Cited by 1,857
Singh, J. A., Furst, D. E., Bharat, A., Curtis, J. R., Kavanaugh, A. F., Kremer, J. M., Moreland, L. W., O'Dell, J., Winthrop, K. L., Beukelman, T., et al. (2012) · Arthritis Care & Research · doi:10.1002/acr.21641 · Cited by 1,789
Impaired immune and acute-phase responses in interleukin-6-deficient mice
Kopf, M., Baumann, H., Freer, G., Freudenberg, M., Lamers, M., Kishimoto, T., Zinkernagel, R., Bluethmann, H., & Köhler, G. (1994) · Nature · doi:10.1038/368339a0 · Cited by 1,768
Elliott, M. J., Maini, R. N., Feldmann, M., Kalden, J. R., Antoni, C., Smolen, J. S., Leeb, B., Breedveld, F. C., Macfarlane, J. D., Bijl, J. A., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90628-9 · Cited by 1,682 · cited 1×
“More importantly, the crucial role of TNF in RA has been confirmed by results from clinical trials in patients treated with TNF inhibitors [68, 67, 177].”
BackgroundTransgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis.
Keffer, J., Probert, L., Cazlaris, H., Georgopoulos, S., Kaslaris, E., Kioussis, D., & Kollias, G. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb04978.x · Cited by 1,660
Moreland, L. W., Baumgartner, S. W., Schiff, M. H., Tindall, E. A., Fleischmann, R. M., Weaver, A. L., Ettlinger, R. E., Cohen, S., Koopman, W. J., Mohler, K., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707173370301 · Cited by 1,622
The JAK-STAT Pathway: Impact on Human Disease and Therapeutic Intervention
O'Shea, J. J., Schwartz, D. M., Villarino, A. V., Gadina, M., McInnes, I. B., & Laurence, A. (2015) · Annual Review of Medicine · doi:10.1146/annurev-med-051113-024537 · Cited by 1,599
The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing
Gaffen, S. L., Jain, R., Garg, A. V., & Cua, D. J. (2014) · Nature reviews. Immunology · doi:10.1038/nri3707 · Cited by 1,585 · cited 1×
“Such activation induces many inflammatory genes, mainly the neutrophil-specific chemokines [89, 250].”
BackgroundSugarman, B. J., Aggarwal, B. B., Hass, P. E., Figari, I. S., Palladino, M. A., & Shepard, H. M. (1985) · Science · doi:10.1126/science.3933111 · Cited by 1,580
T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines
Fossiez, F., Djossou, O., Chomarat, P., Flores-Romo, L., Ait-Yahia, S., Maat, C., Pin, J. J., Garrone, P., Garcia, E., Saeland, S., et al. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.6.2593 · Cited by 1,526 · cited 2×
“This is mediated by the induction of CXC chemokines, including IL8 and growth factors such as GM-CSF [83].”
BackgroundStructure and signalling in the IL-17 receptor family
Gaffen, S. L. (2009) · Nature reviews. Immunology · doi:10.1038/nri2586 · Cited by 1,475 · cited 1×
“In turn, Act1, which also contains a TRAF-binding domain, recruits TRAF6 [150, 203] leading to the activation of the classical NFκB and the MAPK pathway and possibly the phosphoinositide-3 kinase (PI3K) pathway [88].”
BackgroundLam, J., Takeshita, S., Barker, J. E., Kanagawa, O., Ross, F. P., & Teitelbaum, S. L. (2000) · Journal of Clinical Investigation · doi:10.1172/jci11176 · Cited by 1,440 · cited 1×
“TNF is a potent driver of osteoclast formation [142], but it also inhibits osteoblast differentiation”
BackgroundBertolini, D. R., Nedwin, G. E., Bringman, T. S., Smith, D. D., & Mundy, G. R. (1986) · Nature · doi:10.1038/319516a0 · Cited by 1,434
The IL-1 family: regulators of immunity
Sims, J. E., & Smith, D. E. (2010) · Nature Reviews Immunology · doi:10.1038/nri2691 · Cited by 1,418
Targeting IL-17 and TH17 cells in chronic inflammation
Miossec, P., & Kolls, J. K. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3794 · Cited by 1,414
Self-citationInterleukin-17 and Type 17 Helper T Cells
Miossec, P., Korn, T., & Kuchroo, V. K. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0707449 · Cited by 1,409 · cited 2×
“phocytes, dendritic cells, or monocytes [176].”
BackgroundSelf-citationSmolen, J. S., Beaulieu, A., Rubbert-Roth, A., Ramos-Remus, C., Rovensky, J., Alecock, E., Woodworth, T., & Alten, R. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60453-5 · Cited by 1,399
TNF biology, pathogenic mechanisms and emerging therapeutic strategies
Kalliolias, G. D., & Ivashkiv, L. B. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.169 · Cited by 1,387
Colony-stimulating factors in inflammation and autoimmunity
Hamilton, J. A. (2008) · Nature reviews. Immunology · doi:10.1038/nri2356 · Cited by 1,305 · cited 1×
“disorders have an increase of GM-CSF levels and GM-CSFR expression [146, 76, 35, 100, 75].”
BackgroundFunctional Specialization of Interleukin-17 Family Members
Iwakura, Y., Ishigame, H., Saijo, S., & Nakae, S. (2011) · Immunity · doi:10.1016/j.immuni.2011.02.012 · Cited by 1,289
Suppression of Immune Induction of Collagen-Induced Arthritis in IL-17-Deficient Mice
Nakae, S., Nambu, A., Sudo, K., & Iwakura, Y. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.11.6173 · Cited by 1,273
BRENNAN, F. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90430-3 · Cited by 1,129
Evidence that cytokines play a role in rheumatoid arthritis
Brennan, F. M., & McInnes, I. B. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36389 · Cited by 1,103
Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α
Elliott, M. J., Maini, R. N., Feldmann, M., Long‐Fox, A., Charles, P., Katsikis, P., Brennan, F. M., Walker, J., Bijl, H., Ghrayeb, J., et al. (1993) · Arthritis & Rheumatism · doi:10.1002/art.1780361206 · Cited by 1,038
Ishigame, H., Kakuta, S., Nagai, T., Kadoki, M., Nambu, A., Komiyama, Y., Fujikado, N., Tanahashi, Y., Akitsu, A., Kotaki, H., et al. (2009) · Immunity · doi:10.1016/j.immuni.2008.11.009 · Cited by 1,004 · cited 1×
“In these cases, the major function of IL-17 is neutrophil chemotaxis at the infection site which is critical for the microorganism clearance [121].”
BackgroundRegulation of tumour necrosis factor signalling: live or let die
Brenner, D., Blaser, H., & Mak, T. W. (2015) · Nature Reviews Immunology · doi:10.1038/nri3834 · Cited by 998 · cited 1×
“This leads to the assembly of different complexes and distinct functional outcomes [24].”
BackgroundAnti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis.
Williams, R. O., Feldmann, M., & Maini, R. N. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.20.9784 · Cited by 989
Feldmann, M., Brennan, F. M., & Maini, R. N. (1996) · Cell · doi:10.1016/s0092-8674(00)81109-5 · Cited by 970
Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium
Chabaud, M., Durand, J. M., Buchs, N., Fossiez, F., Page, G., Frappart, L., & Miossec, P. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199905)42:5<963::aid-anr15>3.0.co;2-e · Cited by 954
Self-citationPathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman’s disease
Yoshizaki, K., Matsuda, T., Nishimoto, N., Kuritani, T., Taeho, L., Aozasa, K., Nakahata, T., Kawai, H., Tagoh, H., & Komori, T. (1989) · Blood · doi:10.1182/blood.v74.4.1360.1360 · Cited by 928
Akdis, M., Aab, A., Altunbulakli, C., Azkur, K., Costa, R. A., Crameri, R., Duan, S., Eiwegger, T., Eljaszewicz, A., Ferstl, R., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.06.033 · Cited by 912
IL-1 pathways in inflammation and human diseases
Gabay, C., Lamacchia, C., & Palmer, G. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.4 · Cited by 897 · cited 1×
“IL-1, secreted mainly by macrophages, monocytes, and dendritic cells, was the first interleukin to be identified; it was described as a protein-inducing fever with two major proteins, IL-1α and IL-1β encoded by two distinct genes [64, 85, 90].”
BackgroundChen, C.-J., Kono, H., Golenbock, D., Reed, G., Akira, S., & Rock, K. L. (2007) · Nature Medicine · doi:10.1038/nm1603 · Cited by 876 · cited 1×
“This implies that IL-1α acts as an alarmin by rapidly mediating the early phases of sterile inflammation [47].”
BackgroundHueber, W., Patel, D. D., Dryja, T., Wright, A. M., Koroleva, I., Bruin, G., Antoni, C., Draelos, Z., Gold, M. H., the Psoriasis Study Group, et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001107 · Cited by 860
Nishimoto, N., Yoshizaki, K., Miyasaka, N., Yamamoto, K., Kawai, S., Takeuchi, T., Hashimoto, J., Azuma, J., & Kishimoto, T. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20303 · Cited by 788
Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis
Hirano, T., Matsuda, T., Turner, M., Miyasaka, N., Buchan, G., Tang, B., Sato, K., Shimi, M., Maid, R., Feldmann, M., et al. (1988) · European Journal of Immunology · doi:10.1002/eji.1830181122 · Cited by 784
Directing Transition from Innate to Acquired Immunity: Defining a Role for IL-6
Jones, S. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.6.3463 · Cited by 771
Horai, R., Saijo, S., Tanioka, H., Nakae, S., Sudo, K., Okahara, A., Ikuse, T., Asano, M., & Iwakura, Y. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.2.313 · Cited by 749
Nishimoto, N., Hashimoto, J., Miyasaka, N., Yamamoto, K., Kawai, S., Takeuchi, T., Murata, N., van der Heijde, D., & Kishimoto, T. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.068064 · Cited by 727
T-helper-1-cell cytokines drive cancer into senescence
Braumüller, H., Wieder, T., Brenner, E., Aßmann, S., Hahn, M., Alkhaled, M., Schilbach, K., Essmann, F., Kneilling, M., Griessinger, C., et al. (2013) · Nature · doi:10.1038/nature11824 · Cited by 720 · cited 1×
“esis through cytostatic effects such as senescence [224, 21].”
BackgroundLubberts, E., Koenders, M. I., Oppers‐Walgreen, B., van den Bersselaar, L., Coenen‐de Roo, C. J. J., Joosten, L. A. B., & van den Berg, W. B. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20001 · Cited by 709
Ramiro, S., Gaujoux-Viala, C., Nam, J. L., Smolen, J. S., Buch, M., Gossec, L., van der Heijde, D., Winthrop, K., & Landewé, R. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204575 · Cited by 701
Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling
Jones, S. A., Scheller, J., & Rose-John, S. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57158 · Cited by 683
Infections in patients with rheumatoid arthritis treated with biologic agents
Listing, J., Strangfeld, A., Kary, S., Rau, R., von Hinueber, U., Stoyanova‐Scholz, M., Gromnica‐Ihle, E., Antoni, C., Herzer, P., Kekow, J., et al. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21386 · Cited by 681
Soluble gp130 is the natural inhibitor of soluble interleukin‐6 receptor transsignaling responses
Jostock, T., Müllberg, J., Özbek, S., Atreya, R., Blinn, G., Voltz, N., Fischer, M., Neurath, M. F., & Rose‐John, S. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.01867.x · Cited by 641
Cohen, S., Hurd, E., Cush, J., Schiff, M., Weinblatt, M. E., Moreland, L. W., Kremer, J., Bear, M. B., Rich, W. J., & McCabe, D. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10141 · Cited by 638 · cited 2×
“In humans, several studies using an anti-IL-1 therapy (anakinra) demonstrate a significant but moderate improvement of clinical signs of RA [167, 52].”
BackgroundDayer, J. M., de Rochemonteix, B., Burrus, B., Demczuk, S., & Dinarello, C. A. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112350 · Cited by 624
GM-CSF Regulates Alveolar Macrophage Differentiation and Innate Immunity in the Lung through PU.1
Shibata, Y., Berclaz, P.-Y., Chroneos, Z. C., Yoshida, M., Whitsett, J. A., & Trapnell, B. C. (2001) · Immunity · doi:10.1016/s1074-7613(01)00218-7 · Cited by 618
Qian, Y., Liu, C., Hartupee, J., Altuntas, C. Z., Gulen, M. F., Jane-wit, D., Xiao, J., Lu, Y., Giltiay, N., Liu, J., et al. (2007) · Nature Immunology · doi:10.1038/ni1439 · Cited by 614 · cited 5×
“This induces the oligomerization and the activation of TRAF6 that leads to the activation of the transcription factors NFκB and activator protein 1 (AP-1).”
BackgroundInfluentialFleetwood, A. J., Lawrence, T., Hamilton, J. A., & Cook, A. D. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.8.5245 · Cited by 607
Interleukin 6 is required for the development of collagen-induced arthritis
Alonzi, T., Fattori, E., Lazzaro, D., Costa, P., Probert, L., Kollias, G., De Benedetti, F., Poli, V., & Ciliberto, G. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.4.461 · Cited by 604 · cited 2×
“In antigen-induced arthritis (AIA) and CIA, IL-6 plays a key role in the development of the disease [191, 6].”
BackgroundThe involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions
Apte, R. N., Dotan, S., Elkabets, M., White, M. R., Reich, E., Carmi, Y., Song, X., Dvozkin, T., Krelin, Y., & Voronov, E. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-9004-4 · Cited by 593
Hetland, M. L., Christensen, I. J., Tarp, U., Dreyer, L., Hansen, A., Hansen, I. T., Kollerup, G., Linde, L., Lindegaard, H., Poulsen, U. E., et al. (2009) · Arthritis & Rheumatism · doi:10.1002/art.27227 · Cited by 588
Ziolkowska, M., Koc, A., Luszczykiewicz, G., Ksiezopolska-Pietrzak, K., Klimczak, E., Chwalinska-Sadowska, H., & Maslinski, W. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.5.2832 · Cited by 580 · cited 1×
“17 is spontaneously produced by RA synovium [40, 1, 249], and these increased IL-17 levels correlate with more severe”
BackgroundCutting Edge: Interleukin 17 Signals through a Heteromeric Receptor Complex
Toy, D., Kugler, D., Wolfson, M., Bos, T. V., Gurgel, J., Derry, J., Tocker, J., & Peschon, J. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.1.36 · Cited by 570 · cited 4×
“IL-17 binds a heterodimeric receptor composed by IL- 17RA and IL-17RC.”
BackgroundInfluentialGenovese, M. C., Cohen, S., Moreland, L., Lium, D., Robbins, S., Newmark, R., Bekker, P., & for the 20000223 Study Group (2004) · Arthritis & Rheumatism · doi:10.1002/art.20221 · Cited by 532
Metcalf, D. (2008) · Blood · doi:10.1182/blood-2007-03-079681 · Cited by 528
Choy, E. H. S., Isenberg, D. A., Garrood, T., Farrow, S., Ioannou, Y., Bird, H., Cheung, N., Williams, B., Hazleman, B., Price, R., et al. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10623 · Cited by 526 · cited 1×
“significant decreased inflammation and clinical disease activity [187, 49].”
BackgroundNadkarni, S., Mauri, C., & Ehrenstein, M. R. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061531 · Cited by 507
Cytokines in rheumatoid arthritis — shaping the immunological landscape
McInnes, I. B., Buckley, C. D., & Isaacs, J. D. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.171 · Cited by 504
Pettipher, E. R., Higgs, G. A., & Henderson, B. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.22.8749 · Cited by 496
TNF and its receptors in the CNS: The essential, the desirable and the deleterious effects
Probert, L. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.06.038 · Cited by 495
IL-1β Processing in Host Defense: Beyond the Inflammasomes
Netea, M. G., Simon, A., van de Veerdonk, F., Kullberg, B.-J., Van der Meer, J. W. M., & Joosten, L. A. B. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000661 · Cited by 490
Hirota, K., Hashimoto, M., Yoshitomi, H., Tanaka, S., Nomura, T., Yamaguchi, T., Iwakura, Y., Sakaguchi, N., & Sakaguchi, S. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062259 · Cited by 482
Chabaud, M., Fossiez, F., Taupin, J.-L., & Miossec, P. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.1.409 · Cited by 457
Self-citationKing, I. L., Dickendesher, T. L., & Segal, B. M. (2009) · Blood · doi:10.1182/blood-2008-07-168575 · Cited by 444
Joosten, L. A. B., Helsen, M. M., Saxne, T., van de Loo, F. A. J., Heinegård, D. K., & van den Berg, W. B. (1999) · PubMed · Cited by 441
Angiogenesis in rheumatoid arthritis.
Paleolog, E. M. (2002) · Arthritis Research · doi:10.1186/ar575 · Cited by 416
IL-17 Is Produced by Some Proinflammatory Th1/Th0 Cells But Not by Th2 Cells
Aarvak, T., Chabaud, M., Miossec, P., & Natvig, J. B. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.3.1246 · Cited by 410
Self-citationSmolen, J. S., Landewé, R., Breedveld, F. C., Dougados, M., Emery, P., Gaujoux-Viala, C., Gorter, S., Knevel, R., Nam, J., Schoels, M., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.126532 · Cited by 409
How Cytokine Networks Fuel Inflammation: Toward a cytokine-based disease taxonomy
Schett, G., Elewaut, D., McInnes, I. B., Dayer, J.-M., & Neurath, M. F. (2013) · Nature Medicine · doi:10.1038/nm.3260 · Cited by 406
Interleukin 6 plays a key role in the development of antigen-induced arthritis
Ohshima, S., Saeki, Y., Mima, T., Sasai, M., Nishioka, K., Nomura, S., Kopf, M., Katada, Y., Tanaka, T., Suemura, M., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8222 · Cited by 406
Taylor, P. C., Peters, A. M., Paleolog, E., Chapman, P. T., Elliott, M. J., McCloskey, R., Feldmann, M., & Maini, R. N. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200001)43:1<38::aid-anr6>3.0.co;2-l · Cited by 405
Joosten, L. A. B., Helsen, M. M. A., Saxne, T., van de Loo, F. A. J., Heinegård, D., & van den Berg, W. B. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.9.5049 · Cited by 405
IL-17 in Chronic Inflammation: From Discovery to Targeting
Beringer, A., Noack, M., & Miossec, P. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.01.001 · Cited by 402
Self-citationClassical and Paradoxical Effects of TNF-α on Bone Homeostasis
Osta, B., Benedetti, G., & Miossec, P. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00048 · Cited by 387
Self-citationSynovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics
Dennis, G., Holweg, C. T., Kummerfeld, S. K., Choy, D. F., Setiadi, A. F., Hackney, J. A., Haverty, P. M., Gilbert, H., Lin, W. Y., Diehl, L., et al. (2014) · Arthritis Research & Therapy · doi:10.1186/ar4555 · Cited by 380
Loo, F. A. J. V. D., Joosten, L. A. B., Van Lent, P. L. E. M., Arntz, O. J., & Van Den Berg, W. B. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380204 · Cited by 380
Ponomarev, E. D., Shriver, L. P., Maresz, K., Pedras-Vasconcelos, J., Verthelyi, D., & Dittel, B. N. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.1.39 · Cited by 364
Blockade of TNF-α rapidly inhibits pain responses in the central nervous system
Hess, A., Axmann, R., Rech, J., Finzel, S., Heindl, C., Kreitz, S., Sergeeva, M., Saake, M., Garcia, M., Kollias, G., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011774108 · Cited by 356
Butler, D., Maini, R. N., Feldmann, M., & Brennan, F. M. (1995) · PubMed · Cited by 349
Hashizume, M., Hayakawa, N., & Mihara, M. (2008) · Rheumatology · doi:10.1093/rheumatology/ken363 · Cited by 347
Familial autoinflammatory diseases: genetics, pathogenesis and treatment
Stojanov, S., & Kastner, D. L. (2005) · Current Opinion in Rheumatology · doi:10.1097/bor.0000174210.78449.6b · Cited by 346
Animal models of rheumatoid arthritis
Asquith, D. L., Miller, A. M., McInnes, I. B., & Liew, F. Y. (2009) · European Journal of Immunology · doi:10.1002/eji.200939578 · Cited by 345
Anakinra for Rheumatoid Arthritis: A Systematic Review
MERTENS, M., & SINGH, J. A. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.090074 · Cited by 344
Narazaki, M., Yasukawa, K., Saito, T., Ohsugi, Y., Fukui, H., Koishihara, Y., Yancopoulos, G., Taga, T., & Kishimoto, T. (1993) · Blood · doi:10.1182/blood.v82.4.1120.1120 · Cited by 343
Madhok, R., Crilly, A., Watson, J., & Capell, H. A. (1993) · Annals of the Rheumatic Diseases · doi:10.1136/ard.52.3.232 · Cited by 340 · cited 1×
“Furthermore, an overproduction of IL-6 and of sIL-6R is found in the synovial fluid and blood of RA patients and this excess correlates with disease activity and joint destruction [158, 206].”
BackgroundKirkham, B. W., Lassere, M. N., Edmonds, J. P., Juhasz, K. M., Bird, P. A., Lee, C. S., Shnier, R., & Portek, I. J. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21749 · Cited by 336 · cited 1×
“joint damage and disease activity [137, 168].”
Chabaud, M., Lubberts, E., Joosten, L., van den Berg, W., & Miossec, P. (2001) · Arthritis Research & Therapy · doi:10.1186/ar294 · Cited by 333
Self-citationCohen, I., Rider, P., Carmi, Y., Braiman, A., Dotan, S., White, M. R., Voronov, E., Martin, M. U., Dinarello, C. A., & Apte, R. N. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0915018107 · Cited by 329
Cytokine expression in synovial membranes of patients with rheumatoid arthritis and osteoarthritis.
Farahat, M. N., Yanni, G., Poston, R., & Panayi, G. S. (1993) · Annals of the Rheumatic Diseases · doi:10.1136/ard.52.12.870 · Cited by 319
Fleetwood, A. J., Dinh, H., Cook, A. D., Hertzog, P. J., & Hamilton, J. A. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.1108702 · Cited by 312
The Structure of the GM-CSF Receptor Complex Reveals a Distinct Mode of Cytokine Receptor Activation
Hansen, G., Hercus, T. R., McClure, B. J., Stomski, F. C., Dottore, M., Powell, J., Ramshaw, H., Woodcock, J. M., Xu, Y., Guthridge, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.05.053 · Cited by 311
Koenders, M. I., Lubberts, E., Oppers-Walgreen, B., van den Bersselaar, L., Helsen, M. M., Di Padova, F. E., Boots, A. M. H., Gram, H., Joosten, L. A. B., & van den Berg, W. B. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62961-6 · Cited by 310
Hercus, T. R., Thomas, D., Guthridge, M. A., Ekert, P. G., King-Scott, J., Parker, M. W., & Lopez, A. F. (2009) · Blood · doi:10.1182/blood-2008-12-164004 · Cited by 307
The role of IL-1 in the pathogenesis of heart disease
Bujak, M., & Frangogiannis, N. G. (2009) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-009-0024-y · Cited by 307
Haworth, C., Brennan, F. M., Chantry, D., Turner, M., Maini, R. N., & Feldmann, M. (1991) · European Journal of Immunology · doi:10.1002/eji.1830211039 · Cited by 299
Wooley, P. H., Dutcher, J., Widmer, M. B., & Gillis, S. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.11.6602 · Cited by 293
Genovese, M. C., Durez, P., Richards, H. B., Supronik, J., Dokoupilova, E., Mazurov, V., Aelion, J. A., Lee, S.-H., Codding, C. E., Kellner, H., et al. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-201601 · Cited by 293
Recent advances in the IL-17 cytokine family
Gaffen, S. L. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.07.006 · Cited by 283
Interleukin-1 function and role in rheumatic disease
Schett, G., Dayer, J.-M., & Manger, B. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2016.166 · Cited by 279
Haudek, S. B., Taffet, G. E., Schneider, M. D., & Mann, D. L. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29134 · Cited by 278
CONTRIBUTION OF INTERLEUKIN 17 TO SYNOVIUM MATRIX DESTRUCTION IN RHEUMATOID ARTHRITIS
Chabaud, M., Garnero, P., Dayer, J.-M., Guerne, P.-A., Fossiez, F., & Miossec, P. (2000) · Cytokine · doi:10.1006/cyto.2000.0681 · Cited by 277
Self-citationPeters, M., Jacobs, S., Ehlers, M., Vollmer, P., Müllberg, J., Wolf, E., Brem, G., Meyer zum Büschenfelde, K. H., & Rose-John, S. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.4.1399 · Cited by 276
Tumour necrosis factor antagonists: structure, function, and tuberculosis risks
Wallis, R. S. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70227-5 · Cited by 275
Human leukocytic pyrogen: purification and development of a radioimmunoassay.
Dinarello, C. A., Renfer, L., & Wolff, S. M. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.10.4624 · Cited by 272
Miossec, P. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10816 · Cited by 264
Self-citationTargeting GM-CSF in inflammatory diseases
Wicks, I. P., & Roberts, A. W. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.161 · Cited by 259
Xu, W. D., Firestein, G. S., Taetle, R., Kaushansky, K., & Zvaifler, N. J. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113971 · Cited by 258
The STIR-domain superfamily in signal transduction, development and immunity
Novatchkova, M., Leibbrandt, A., Werzowa, J., Neubüser, A., & Eisenhaber, F. (2003) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(03)00067-7 · Cited by 255 · cited 3×
“Both chains contain a conserved signaling domain, the SEF/IL-17R (SEFIR) [189] which recruits the ubiquitin ligase Act1 through its own SEFIR [87, 203].”
BackgroundInfluentialTrans-Signaling Is a Dominant Mechanism for the Pathogenic Actions of Interleukin-6 in the Brain
Campbell, I. L., Erta, M., Lim, S. L., Frausto, R., May, U., Rose-John, S., Scheller, J., & Hidalgo, J. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.2830-13.2014 · Cited by 247
van der Meer, J. W., Barza, M., Wolff, S. M., & Dinarello, C. A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.5.1620 · Cited by 243
The Roles of Interleukin-6 in the Pathogenesis of Rheumatoid Arthritis
Hashizume, M., & Mihara, M. (2011) · Arthritis · doi:10.1155/2011/765624 · Cited by 238
Chabaud, M., Page, G., & Miossec, P. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.10.6015 · Cited by 234
Self-citationCampbell, I. K., Rich, M. J., Bischof, R. J., Dunn, A. R., Grail, D., & Hamilton, J. A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.7.3639 · Cited by 234
Fujimoto, M., Serada, S., Mihara, M., Uchiyama, Y., Yoshida, H., Koike, N., Ohsugi, Y., Nishikawa, T., Ripley, B., Kimura, A., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.24126 · Cited by 225
Act1, a U-box E3 Ubiquitin Ligase for IL-17 Signaling
Liu, C., Qian, W., Qian, Y., Giltiay, N. V., Lu, Y., Swaidani, S., Misra, S., Deng, L., Chen, Z. J., & Li, X. (2009) · Science Signaling · doi:10.1126/scisignal.2000382 · Cited by 224 · cited 5×
“This induces the oligomerization and the activation of TRAF6 that leads to the activation of the transcription factors NFκB and activator protein 1 (AP-1).”
BackgroundInfluentialHuizinga, T. W. J., Fleischmann, R. M., Jasson, M., Radin, A. R., van Adelsberg, J., Fiore, S., Huang, X., Yancopoulos, G. D., Stahl, N., & Genovese, M. C. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204405 · Cited by 222
Genovese, M. C., Fleischmann, R., Kivitz, A. J., Rell‐Bakalarska, M., Martincova, R., Fiore, S., Rohane, P., van Hoogstraten, H., Garg, A., Fan, C., et al. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39093 · Cited by 219
Genovese, M. C., Greenwald, M., Cho, C., Berman, A., Jin, L., Cameron, G. S., Benichou, O., Xie, L., Braun, D., Berclaz, P., et al. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38617 · Cited by 211 · cited 1×
“ixekizumab has reached a similar conclusion [97].”
The Role of IL-1β in the Early Tumor Cell–Induced Angiogenic Response
Carmi, Y., Dotan, S., Rider, P., Kaplanov, I., White, M. R., Baron, R., Abutbul, S., Huszar, M., Dinarello, C. A., Apte, R. N., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202769 · Cited by 209
Functions of Granulocyte-Macrophage Colony-Stimulating Factor
Fleetwood, A. J., Cook, A. D., & Hamilton, J. A. (2005) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v25.i5.50 · Cited by 203
Pivotal Roles of GM‐CSF in Autoimmunity and Inflammation
Shiomi, A., & Usui, T. (2015) · Mediators of Inflammation · doi:10.1155/2015/568543 · Cited by 201
MIHARA, M., MORIYA, Y., KISHIMOTO, T., & OHSUGI, Y. (1995) · Rheumatology · doi:10.1093/rheumatology/34.4.321 · Cited by 198
Chabaud, M., & Miossec, P. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200106)44:6<1293::aid-art221>3.0.co;2-t · Cited by 197
Self-citationThe Role of IL‐1 and IL‐1Ra in Joint Inflammation and Cartilage Degradation
Jacques, C., Gosset, M., Berenbaum, F., & Gabay, C. (2006) · Vitamins & Hormones · doi:10.1016/s0083-6729(06)74016-x · Cited by 196
Immunogenicity and autoimmunity during anti-TNF therapy
Atzeni, F., Talotta, R., Salaffi, F., Cassinotti, A., Varisco, V., Battellino, M., Ardizzone, S., Pace, F., & Sarzi-Puttini, P. (2013) · Autoimmunity Reviews · doi:10.1016/j.autrev.2012.10.021 · Cited by 196
Hematopoietic colony–stimulating factors mediate tumor-nerve interactions and bone cancer pain
Schweizerhof, M., Stösser, S., Kurejova, M., Njoo, C., Gangadharan, V., Agarwal, N., Schmelz, M., Bali, K. K., Michalski, C. W., Brugger, S., et al. (2009) · Nature Medicine · doi:10.1038/nm.1976 · Cited by 191
Jones, G. W., McLoughlin, R. M., Hammond, V. J., Parker, C. R., Williams, J. D., Malhotra, R., Scheller, J., Williams, A. S., Rose-John, S., Topley, N., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0901528 · Cited by 189 · cited 1×
“sive to IL-6 through the trans-signaling pathway [125, 120].”
BackgroundCook, A. D., Braine, E. L., Campbell, I. K., Rich, M. J., & Hamilton, J. A. (2001) · Arthritis Research & Therapy · doi:10.1186/ar318 · Cited by 186
Fleischmann, R., van Adelsberg, J., Lin, Y., Castelar‐Pinheiro, G. D. R., Brzezicki, J., Hrycaj, P., Graham, N. M. H., van Hoogstraten, H., Bauer, D., & Burmester, G. R. (2017) · Arthritis & Rheumatology · doi:10.1002/art.39944 · Cited by 178
Constitutive production of interleukin‐6 and immunologic features in cardiac myxomas
Jourdan, M., Bataille, R., Seguin, J., Zhang, X. G., Chaptal, P. A., & Klein, B. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330313 · Cited by 168
Predictors for remission in rheumatoid arthritis patients: A systematic review
Katchamart, W., Johnson, S., Lin, H. L., Phumethum, V., Salliot, C., & Bombardier, C. (2010) · Arthritis Care & Research · doi:10.1002/acr.20188 · Cited by 168
Lee, A., Qiao, Y., Grigoriev, G., Chen, J., Park‐Min, K., Park, S. H., Ivashkiv, L. B., & Kalliolias, G. D. (2013) · Arthritis & Rheumatism · doi:10.1002/art.37853 · Cited by 163
Metawi, S. A., Abbas, D., Kamal, M. M., & Ibrahim, M. K. (2011) · Clinical Rheumatology · doi:10.1007/s10067-011-1737-y · Cited by 163
Alten, R., Gómez-Reino, J. J., Durez, P., Beaulieu, A. D., Sebba, A. I., Krammer, G., Preiss, R., Arulmani, U., Widmer, A., Gitton, X., et al. (2011) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-12-153 · Cited by 161
Interleukin 17 contributes to the chronicity of inflammatory diseases such as rheumatoid arthritis
Benedetti, G., & Miossec, P. (2014) · European Journal of Immunology · doi:10.1002/eji.201344184 · Cited by 160
Self-citationTNF Receptor 2 and Disease: Autoimmunity and Regenerative Medicine
Faustman, D. L., & Davis, M. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00478 · Cited by 160
Efficacy and safety of mavrilimumab in subjects with rheumatoid arthritis
Burmester, G. R., Weinblatt, M. E., McInnes, I. B., Porter, D., Barbarash, O., Vatutin, M., Szombati, I., Esfandiari, E., Sleeman, M. A., Kane, C. D., et al. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202450 · Cited by 157
Carrieri, P. B., Provitera, V., Rosa, T. D., Tartaglia, G., Gorga, F., & Perrella, O. (1998) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923979809034820 · Cited by 156
Skiniotis, G., Boulanger, M. J., García, K. C., & Walz, T. (2005) · Nature Structural & Molecular Biology · doi:10.1038/nsmb941 · Cited by 154
Arend, W. P. (2001) · Seminars in Arthritis and Rheumatism · doi:10.1053/sarh.2001.23693 · Cited by 154
IL-6 Controls the Innate Immune Response against Listeria monocytogenes via Classical IL-6 Signaling
Hoge, J., Yan, I., Jänner, N., Schumacher, V., Chalaris, A., Steinmetz, O. M., Engel, D. R., Scheller, J., Rose-John, S., & Mittrücker, H.-W. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201044 · Cited by 152
Lubberts, E., Joosten, L. A. B., van de Loo, F. A. J., Schwarzenberger, P. O., Kolls, J., & van den Berg, W. B. (2002) · Inflammation Research · doi:10.1007/bf02684010 · Cited by 152
Liu, F., Poursine-Laurent, J., Wu, H. Y., & Link, D. C. (1997) · Blood · doi:10.1182/blood.v90.7.2583 · Cited by 150
The colony-stimulating factors and cancer
Metcalf, D. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2843 · Cited by 149
Behrens, F., Tak, P. P., Østergaard, M., Stoilov, R., Wiland, P., Huizinga, T. W., Berenfus, V. Y., Vladeva, S., Rech, J., Rubbert-Roth, A., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204816 · Cited by 148
Hazenberg, B., van Leeuwen, M., van Rijswijk, M., Ac, S., & Vellenga, E. (1989) · Blood · doi:10.1182/blood.v74.8.2769.2769 · Cited by 144
IL-6 Is Required for Airway Mucus Production Induced by Inhaled Fungal Allergens
Neveu, W. A., Allard, J. B., Dienz, O., Wargo, M. J., Ciliberto, G., Whittaker, L. A., & Rincon, M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802923 · Cited by 141
The problem of choice: current biologic agents and future prospects in RA
Choy, E. H., Kavanaugh, A. F., & Jones, S. A. (2013) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2013.8 · Cited by 141
Interleukin-6 in synovial fluid is closely associated with chronic synovitis in rheumatoid arthritis
Sack, U., Kinne, R. W., Marx, T., Heppt, P., Bender, S., & Emmrich, F. (1993) · Rheumatology International · doi:10.1007/bf00307733 · Cited by 140
Smolen, J. S., Weinblatt, M. E., Sheng, S., Zhuang, Y., & Hsu, B. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-205137 · Cited by 139
Intracellular Signaling Pathways in Rheumatoid Arthritis
Malemud, C. J. (2013) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000160 · Cited by 138
Effects of Interleukin-17A on Osteogenic Differentiation of Isolated Human Mesenchymal Stem Cells
Osta, B., Lavocat, F., Eljaafari, A., & Miossec, P. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00425 · Cited by 138
Self-citationInterleukin-17, a regulator of angiogenic factor release by synovial fibroblasts
Honorati, M. C., Neri, S., Cattini, L., & Facchini, A. (2005) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2005.10.004 · Cited by 137
Zrioual, S., Toh, M.-L., Tournadre, A., Zhou, Y., Cazalis, M.-A., Pachot, A., Miossec, V., & Miossec, P. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.1.655 · Cited by 137
Self-citationOpposing Functions of Classic and Novel IL-1 Family Members in Gut Health and Disease
Lopetuso, L. R., Chowdhry, S., & Pizarro, T. T. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00181 · Cited by 133
Genovese, M. C., Fleischmann, R., Furst, D., Janssen, N., Carter, J., Dasgupta, B., Bryson, J., Duncan, B., Zhu, W., Pitzalis, C., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204760 · Cited by 132
Tocilizumab in the treatment of rheumatoid arthritis and beyond
Sweiss, N., Shetty, A., Hanson, R. L., Korsten, P., Arami, S., Volkov, S., Vila, O. M., Swedler, W. I., Shahrara, S., Smadi, S., et al. (2014) · Drug Design Development and Therapy · doi:10.2147/dddt.s41437 · Cited by 132
Ghivizzani, S. C., Kang, R., Georgescu, H. I., Lechman, E. R., Jaffurs, D., Engle, J. M., Watkins, S. C., Tindal, M. H., Suchanek, M. K., McKenzie, L. R., et al. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.7.3604 · Cited by 130
Burmester, G. R., Feist, E., Sleeman, M., Wang, B., White, B., & Magrini, F. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.146225 · Cited by 130
Ulfgren, A. ‐., Gröndal, L., Lindblad, S., Khademi, M., Johnell, O., Klareskog, L., & Andersson, U. (2000) · Annals of the Rheumatic Diseases · doi:10.1136/ard.59.6.439 · Cited by 127
Cook, A. D., Pobjoy, J., Steidl, S., Dürr, M. C., Braine, E. L., Turner, A. L., Lacey, D. C., & Hamilton, J. A. (2012) · Arthritis Research & Therapy · doi:10.1186/ar4037 · Cited by 126
Leizer, T., Cebon, J., Layton, J., & Hamilton, J. (1990) · Blood · doi:10.1182/blood.v76.10.1989.1989 · Cited by 125
Isomäki, P., Junttila, I., Vidqvist, K.-L., Korpela, M., & Silvennoinen, O. (2015) · Rheumatology · doi:10.1093/rheumatology/keu430 · Cited by 116
Rose‐John, S., & Neurath, M. F. (2004) · Immunity · doi:10.1016/s1074-7613(04)00003-2 · Cited by 115
Signalling by the βc family of cytokines
Hercus, T. R., Dhagat, U., Kan, W. L., Broughton, S. E., Nero, T. L., Perugini, M., Sandow, J. J., D’Andrea, R. J., Ekert, P. G., Hughes, T. P., et al. (2013) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2013.03.002 · Cited by 113
The Colony-Stimulating Factors and Cancer
Metcalf, D. (2013) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0151 · Cited by 113
Granulocyte-macrophage colony stimulating factor exacerbates collagen induced arthritis in mice
Campbell, I. K., Bendele, A. M., Smith, D. A., & Hamilton, J. A. (1997) · Annals of the Rheumatic Diseases · doi:10.1136/ard.56.6.364 · Cited by 110
Martin, D. A., Churchill, M., Flores-Suarez, L. F., Cardiel, M. H., Wallace, D., Martin, R., Phillips, K., Kaine, J. L., Dong, H., Salinger, D., et al. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4347 · Cited by 107
GM-CSF as a therapeutic target in inflammatory diseases
van Nieuwenhuijze, A. E. M., Koenders, M. I., Roeleveld, D. M., Sleeman, M. A., van den Berg, W., & Wicks, I. P. (2013) · Molecular Immunology · doi:10.1016/j.molimm.2013.05.002 · Cited by 105
Drevlow, B. E., Lovis, R., Haag, M. A., Sinacore, J. M., Jacobs, C., Blosche, C., Landay, A., Moreland, L. W., & Pope, R. M. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390212 · Cited by 103
van Lent, P. L., van de Loo, F. A. J., Holthuysen, A. E. M., van den Bersselaar, L. A., Vermeer, H. A. B., & van den Berg, W. B. (1995) · PubMed · Cited by 100
Tanaka, Y., & Mola, E. M. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-205002 · Cited by 100
Bresnihan, B. (2001) · Seminars in Arthritis and Rheumatism · doi:10.1053/sarh.2001.23701 · Cited by 99
Mease, P. J., Strand, V., Shalamberidze, L., Dimić, A., Raskina, T. A., Xu, L., Liu, Y., & Smith, J. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200704 · Cited by 99
Weinblatt, M. E., Mease, P., Mysler, E., Takeuchi, T., Drescher, E., Berman, A., Xing, J., Zilberstein, M., Banerjee, S., & Emery, P. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39249 · Cited by 98
Genovese, M. C., Durez, P., Richards, H. B., Supronik, J., Dokoupilova, E., Aelion, J. A., Lee, S.-H., Codding, C. E., Kellner, H., Ikawa, T., et al. (2014) · The Journal of Rheumatology · doi:10.3899/jrheum.130637 · Cited by 96
Cook, A. D., Pobjoy, J., Sarros, S., Steidl, S., Dürr, M. C., Lacey, D. C., & Hamilton, J. A. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-201703 · Cited by 93
Ghivizzani, S., Lechman, E. R., Tio, C., Mulé, K., Chada, S., McCormack, J., Evans, C. H., & Robbins, P. (1997) · Gene Therapy · doi:10.1038/sj.gt.3300486 · Cited by 91
Toh, M., Gonzales, G., Koenders, M. I., Tournadre, A., Boyle, D., Lubberts, E., Zhou, Y., Firestein, G. S., van den Berg, W. B., & Miossec, P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013416 · Cited by 90
Self-citationTargeting Interleukin-6 in Rheumatoid Arthritis
Yusof, M. Y. M., & Emery, P. (2013) · Drugs · doi:10.1007/s40265-013-0018-2 · Cited by 88
Targeting interleukin‐1 in the treatment of rheumatoid arthritis
Dayer, J., & Bresnihan, B. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10168 · Cited by 88
Lubberts, E., Schwarzenberger, P., Huang, W., Schurr, J. R., Peschon, J. J., van den Berg, W. B., & Kolls, J. K. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.5.3360 · Cited by 85
Pavelka, K., Chon, Y., Newmark, R., Lin, S.-L., Baumgartner, S., & Erondu, N. (2015) · The Journal of Rheumatology · doi:10.3899/jrheum.141271 · Cited by 83 · cited 1×
“a monoclonal antibody directed against IL-17RA, brodalumab had no effect [195, 161], perhaps due to an inhibition of the”
BackgroundRemission in Rheumatoid Arthritis: Wishful Thinking or Clinical Reality?
Sesin, C. A., & Bingham, C. O. (2005) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2005.06.003 · Cited by 82
Campbell, I. K., Novak, U., Cebon, J., Layton, J. E., & Hamilton, J. A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.4.1238 · Cited by 81
Sustained biologic-free and drug-free remission in rheumatoid arthritis, where are we now?
Nagy, G., & van Vollenhoven, R. F. (2015) · Arthritis Research & Therapy · doi:10.1186/s13075-015-0707-1 · Cited by 78
Cited by
The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases
Cabral-Pacheco, G. A., Garza-Veloz, I., Castruita-De la Rosa, C., Ramirez-Acuña, J. M., Perez-Romero, B. A., Guerrero-Rodriguez, J. F., Martinez-Avila, N., & Martinez-Fierro, M. L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249739 · Cited by 1,820
Age and Age-Related Diseases: Role of Inflammation Triggers and Cytokines
Rea, I. M., Gibson, D. S., McGilligan, V., McNerlan, S. E., Alexander, H. D., & Ross, O. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00586 · Cited by 1,267
“As RA progresses, immune cells and synovial fibroblasts produce a proinflammatory environment in the joint (306, 307) leading to joint destruction (302).”
BackgroundZhang, Q., Dehaini, D., Zhang, Y., Zhou, J., Chen, X., Zhang, L., Fang, R. H., Gao, W., & Zhang, L. (2018) · Nature Nanotechnology · doi:10.1038/s41565-018-0254-4 · Cited by 958
Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer
Xue, C., Yao, Q., Gu, X., Shi, Q., Yuan, X., Chu, Q., Bao, Z., Lu, J., & Li, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01468-7 · Cited by 699
Signaling pathways in rheumatoid arthritis: implications for targeted therapy
Ding, Q., Hu, W., Wang, R., Yang, Q., Zhu, M., Li, M., Cai, J., Rose, P., Mao, J., & Zhu, Y. Z. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01331-9 · Cited by 478
Metadata
- Authors
- Noack, M., & Miossec, P.
- Venue
- Seminars in Immunopathology
- Published
- 2017-02-17
- Volume
- 39
- Issue
- 4
- Pages
- 365-383
- ISSN
- 1863-2297 (ISSN-L)
- 1863-2300
- OpenAlex
- W2589082990
- Cited by
- 303
- References
- 234
- FWCI
- 21.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.